Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer

Despite advances in colon cancer research and novel therapies, high risk of recurrence remains a major challenge. This study reports miRNA expression profiling as a biomarker for the prognosis of TNM stage II and III colon cancer. Fresh frozen biopsies from the study cohort (N=111) were analyzed for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Jacob, Havjin, Stanisavljevic, Luka, Storli, Kristian Eeg, Hestetun, Kjersti E, Dahl, Olav, Myklebust, Mette P
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2017
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5675676/
https://ncbi.nlm.nih.gov/pubmed/29152124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21237
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge